Ligne de temps

Sylvie van Der Werf
Responsable de Structure
01 janv. 2025
07 oct. 2024
publication
Profiling Cullin4-E3 ligases interactomes and their rewiring in influenza A virus infection.
Lire plus26 sept. 2024
publication
Levels and functionality of Pacific Islanders’ hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia.
Lire plus19 juil. 2024
publication
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2.
Lire plus08 sept. 2023
publication
Genotype and Phenotype Characterization of Rhinolophus sp. Sarbecoviruses from Vietnam: Implications for Coronavirus Emergence.
Lire plus21 avr. 2023
publication
Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages.
Lire plus05 avr. 2023
publication
SARS‐CoV‐2‐related bat virus behavior in human‐relevant models sheds light on the origin of COVID‐19
Lire plus15 mars 2023
project
CoVariant – Comprendre les déterminants de l’immunité muqueuse et optimiser le diagnostic de l’infection aux variants du SARS-CoV-2
Lire plus07 févr. 2023
publication
High-throughput droplet-based analysis of influenza A virus genetic reassortment by single-virus RNA sequencing.
Lire plus01 sept. 2022
publication
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.
Lire plus15 juil. 2022
publication
Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1.
Lire plus15 juil. 2022
publication
C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus.
Lire plus04 juil. 2022
publication
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Lire plus17 juin 2022
news
New publication – Potent Human Broadly SARS-CoV-2 Neutralizing IgA and IgG Antibodies Effective Against Omicron BA.1 and BA.2
Lire plus04 mai 2022
publication
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen.
Lire plus01 mai 2022
14 avr. 2022
07 mars 2022
01 mars 2022
publication
sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs.
Lire plus01 mars 2022
publication
Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022.
Lire plus15 févr. 2022
publication
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection.
Lire plus03 févr. 2022
publication
A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection.
Lire plus01 févr. 2022
publication
A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study.
Lire plus21 janv. 2022
publication
Is the Alpha Variant of SARS-CoV-2 Associated with a Higher Viral Load than the Historical Strain in Saliva Samples in Patients with Mild to Moderate Symptoms?
Lire plus01 janv. 2022
publication
Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection.
Lire plus01 janv. 2022
publication
Detection of Phenuiviridae, Chuviridae Members, and a Novel Quaranjavirus in Hard Ticks From Danube Delta.
Lire plus14 déc. 2021
01 sept. 2021
publication
Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France.
Lire plus26 juil. 2021
news
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France
Lire plus22 juil. 2021
publication
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.
Lire plus21 mai 2021
publication
Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance.
Lire plus01 mai 2021
publication
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.
Lire plus20 janv. 2021
publication
Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification
Lire plus01 déc. 2020
06 nov. 2020
news
Suivi de la persistance de la réponse immunitaire contre le SARS-CoV-2 au sein de la cohorte de Crépy-en-Valois (COVID-Oise)
Lire plus22 sept. 2020
publication
Influenza A virus co-opts ERI1 exonuclease bound to histone mRNA to promote viral transcription.
Lire plus02 sept. 2020
publication
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
Lire plus04 août 2020
publication
Highly performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification.
Lire plus01 juil. 2020
publication
Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March 2020.
Lire plus02 avr. 2020
01 mars 2020
publication
Émergence du coronavirus SARS-CoV-2 : faire face à l’épidémie de COVID-19 Facing challenges with the novel coronavirus SARS-CoV-2 outbreak
Lire plus31 janv. 2020
28 janv. 2020
19 oct. 2017
publication
Characterizing and Comparing the Seasonality of Influenza-Like Illnesses and Invasive Pneumococcal Diseases Using Seasonal Waveforms
Lire plus03 juil. 2015
30 sept. 2014
publication
Chimeric NP non coding regions between type A and C influenza viruses reveal their role in translation regulation
Lire plus21 nov. 2013
publication
The Panhandle formed by influenza A and C virus NS non-coding regions determines NS segment expression
Lire plus13 nov. 2013
publication
Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility
Lire plus05 nov. 2013
publication
Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A(H1N1) viruses
Lire plus19 juin 2013
publication
Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models
Lire plus13 mai 2009
publication
April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission
Lire plus30 oct. 2008
publication
Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes
Lire plus08 août 2007
29 mai 2007
01 janv. 2007
publication
Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus.
Lire plus03 nov. 2005
publication
Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5′ terminal sequence: induction of heterospecific B and T cell responses in mice
Lire plus01 nov. 2005
publication
Cloning of the chicken RNA polymerase I promoter and use for reverse genetics of influenza A viruses in avian cells
Lire plus10 oct. 2005
publication
The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5′ end of the PB2 segment
Lire plus15 août 2003
publication
Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter
Lire plus16 mai 2003
publication
A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice.
Lire plus25 nov. 2002
publication
Differential effect of nucleotide substitutions in the 3′ arm of the influenza A virus vRNA promoter on transcription/replication by avian and human polymerase complexes is related to the nature of PB2 amino acid 627
Lire plus01 mai 2002
publication